HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 3,662,098 shares, a decrease of 17.0% from the December 31st total of 4,411,284 shares. Currently, 4.4% of the company’s stock are sold short. Based on an average daily trading volume, of 1,288,427 shares, the short-interest ratio is presently 2.8 days. Based on an average daily trading volume, of 1,288,427 shares, the short-interest ratio is presently 2.8 days. Currently, 4.4% of the company’s stock are sold short.
Insider Buying and Selling
In related news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. The trade was a 1.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 13,959 shares of company stock valued at $1,344,957. 1.50% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On HealthEquity
Several institutional investors and hedge funds have recently modified their holdings of the stock. Simplify Asset Management Inc. bought a new stake in shares of HealthEquity during the third quarter worth $1,498,000. Westfield Capital Management Co. LP lifted its holdings in HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares in the last quarter. GDS Wealth Management lifted its holdings in HealthEquity by 15.7% during the 3rd quarter. GDS Wealth Management now owns 100,969 shares of the company’s stock valued at $9,569,000 after buying an additional 13,682 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. purchased a new stake in HealthEquity in the 2nd quarter valued at about $492,000. Finally, Artisan Partners Limited Partnership grew its stake in HealthEquity by 44.8% in the 2nd quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company’s stock worth $65,124,000 after acquiring an additional 192,252 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Analysis on HQY
HealthEquity Price Performance
Shares of HQY traded up $0.14 during trading hours on Wednesday, reaching $82.26. 262,135 shares of the stock traded hands, compared to its average volume of 1,090,787. HealthEquity has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The company has a market cap of $7.03 billion, a P/E ratio of 37.67, a price-to-earnings-growth ratio of 1.08 and a beta of 0.24. The company’s 50-day moving average price is $92.05 and its two-hundred day moving average price is $93.29.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, analysts anticipate that HealthEquity will post 2.32 earnings per share for the current year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Stories
- Five stocks we like better than HealthEquity
- Why This NYSE Biotech Matters in 2026
- 1 Hour Once A Day
- [No Brainer Gold Play]: “Show me a better investment.”
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
